On going investigation against GlaxoSmithKline in connection with its drug, Avandia. Avandia was designed to treat type II diabetes. Avandia, the drug developed, marketed and distributed to treat Type II diabetes mellitus, caused serious side effects, notably cardiovascular problems, including heart attack, heart failure, and primary pulmonary hypertension ("HPP"). Moreover, women taking Avandia may be exposed to a higher risk of bone fracture. On June 14, 2007, the New England Journal of Medicine released a study which found that there was an increased risk of heart attacks by 43%. On November 14, 2007, the Food & Drug Administration required GlaxoSmithKline add a "black box" to the label warning consumers of s cardiovascular risk.
Do not change medications without first consulting your doctor.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.